Interpace Diagnostics (Exotistan) Story

Macroaxis does not monitor all media channels or aggregates social signals for Interpace Diagnostics. But even though we do not provide professional-grade financial sentiment analysis on Interpace Diagnostics, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Interpace Diagnostics. Additionally take a look at Your Equity Center.
A Technical Perspective on Interpace Diagnostics Group, Inc.
Interpace Diagnostics Group, Inc. declined -4.52 percent and closed its last trading session at 1.48. Its opening price on the last trading day was 1.55. Analysts Swing to Diverse Views for Interpace Diagnostics Group, Inc. IDXG ... - Post Analyst Interpace Diagnostics Group and CBIZ Head-To-Head Review - The Ledger Gazette

Read More...   

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Interpace Diagnostics

Interpace Diagnostics Group Inc PT Lowered to 3 at Maxim GroupStreet Insider News
Maxim Group lowered its price target on Interpace Diagnostics Group Inc to 3.00 while maintaining a Buy rating. At 0.9749, Is It Time To Buy Interpace Diagnostics Group Inc - Simply Wall St Now Offering Discount Or Premium Puma Biotechnology, Inc. , Interpace ... - Post Analyst
over a month ago at http://allstocknews.com 
Overview Of Different Chart Patterns Interpace Diagnostics Group, Inc. IDXG ...
news
Interpace Diagnostics Group, Inc. trades at 1.06 having a market capitalization of 28.29 million. IDXG stock price lost -83.04 percent over the past year, yielding a negative weighted alpha of -66.6 percent.
over three months ago at http://www.nystocknews.com 
Interpace Diagnostics Group, Inc. Underpriced by 76
news
Publicly-traded company Interpace Diagnostics Group, Inc. had a closing price of 1.20 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently 5.00, this means that the stock is underpriced by 76. Bounding Shares, What Next for Interpace Diagnostics Group, Inc. - Morgan Research Eye Catching Stocks Interpace Diagnostics Group, Inc., , Roku ... - Stocks In The News
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Current Asset

Current Asset Comparative Analysis
Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Peers

Your Trending Equities
CVS  2.00 %   
0%
100.0%
HD  0.92 %   
0%
45.0%
T  0.38 %   
0%
18.0%
IBM  0.30 %   
0%
15.0%
AAPL  0.0406 %   
0%
2.0%
WFC  0.12 %   
5.0%
0%
AAL  0.17 %   
8.0%
0%
BBY  0.19 %   
9.0%
0%
MET  0.19 %   
9.0%
0%
C  0.34 %   
16.0%
0%
CVX  0.35 %   
17.0%
0%
AA  0.44 %   
22.0%
0%
TGT  0.45 %   
22.0%
0%
INTC  0.78 %   
39.0%
0%
UPS  1.76 %   
88.0%
0%
S  1.82 %   
91.0%
0%